ArticleJournal of cellular and molecular medicine2024

Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.